DOCK2 deficiency is a disease with a very poor prognosis in patients who do not undergo hematopoietic stem cell transplantation (HSCT) (D'Astous-Gauthier et al., 2021). The gene discussed is DOCK2; the disease is hyperinsulinemic hypoglycemia, familial, 4.